Navigation Links
Omnicell Announces Completion of Its Common Stock Repurchase Plan
Date:3/12/2008

MOUNTAIN VIEW, Calif., March 12 /PRNewswire-FirstCall/ -- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, announced today that it has completed its $40.0 million program to repurchase shares of its Common Stock. A total of 2,133,898 shares were repurchased at an average price of $18.75.

About Omnicell

Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of systems and software solutions targeting patient safety and operational efficiency in healthcare facilities. Since 1992, Omnicell has worked to enhance patient safety and allow clinicians to spend more time with their patients.

Omnicell's medication-use product line includes solutions for the central pharmacy, nursing unit, operating room, and patient bedside. Solutions range from large central pharmacy "smart inventory" carousels to small handheld devices. From the point at which a medication arrives at the receiving dock to the time it is administered, Omnicell systems store it, package it, bar code it, order it, issue it, and provide information and controls on its use and reorder.

Omnicell's supply product lines provide a healthcare institution with fast, effective control of costs, capture of charges for payer reimbursement, and timely reorder of supplies. Products range from high-security closed-cabinet systems and software to open-shelf and combination solutions in the nursing unit, cath lab and operating room.

Omnicell's mission is to provide the best customer experience in healthcare, helping hospitals reduce medication errors, operate more efficiently, and decrease costs. For more information, visit http://www.omnicell.com.


'/>"/>
SOURCE Omnicell, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Omnicell Announces Common Stock Repurchase Program; Reaffirms Earnings Forecast
2. Hospital Environments Increase Staff Efficiency and Patient Safety With Omnicell OptiFlex(TM) SS 9.0
3. Omnicell Schedules Fourth Quarter Earnings Call
4. Omnicell Debuts Industrys First Total Automated Patient-Specific Management Solution
5. Omnicell Announces Agreement to Acquire Rioux Vision, Inc.
6. Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference
7. Hendricks Regional Health Increases Patient Safety and Pharmacy Efficiency With Omnicell WorkflowRx 5.0
8. Omnicell Reports Strong Q3 Revenue and Profit Growth
9. Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems
10. Omnicell Schedules Third Quarter Earnings Call
11. Omnicell Introduces the Next Generation Central Pharmacy Automation Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... ... leading digital and print media enterprise focused on cancer patients, cancer centers and ... released a special 12-part educational video series, “No Ifs, Ands, or Butts,” that ...
(Date:3/22/2017)... ... 22, 2017 , ... The Rett Syndrome Research Trust (RSRT) ... that afflicts 350,000 individuals worldwide. Rett Syndrome is caused by alterations in ... females. Following a normal infancy, Rett Syndrome takes effect in toddlerhood depriving ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... to its Department of Orthopedic Surgery, Division of Hand, Upper Extremity and Microvascular ... surgery. She is board-certified in both Orthopedics and Hand Surgery. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic Imaging, ... therapeutic experience and operational excellence in oncology clinical trials, proudly announces today that ... treatment of non-small cell lung cancer and small cell lung cancer. , Throughout ...
(Date:3/22/2017)... Norwich, NY (PRWEB) , ... March 22, 2017 , ... ... to communities in the greater Nassau County region, is embarking on a combined charity ... breast cancer. , For the last 25 years, the Great Neck Breast Cancer ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... March 22, 2017 AMRI , a ... been working with the life sciences industry to improve ... 25 years, has been recognized for its excellence as ... as part of the Life Science Leader,s 2017 ... expertise, quality and reliability. "Competing with ...
(Date:3/22/2017)... STOCKHOLM , March 22, 2017 ... biopharmaceutical company developing novel anticancer therapies targeting the ... with Memorial Sloan Kettering Cancer Center to study ... p53 by APR-246. The goal of ... efficacy of APR-246 in combination with multiple other ...
(Date:3/22/2017)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 14.58% during the period ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Medicine Technology: